No Prescription |
 |
 | ||
|
NATRILIX SR Lozol |
|
| ||
No Prescription » Prescription Drugs 11 » NATRILIX SR Lozol Indapamide a 'water pill ' is used to reduce the swelling and fluid retention caused by heart disease. It also is used to treat high blood pressure. It causes the kidneys to get rid of unneeded water and salt from the body into the urine.Indapamide comes as a tablet to take by mouth. It usually is taken once a day in the morning. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take indapamide exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Indapamide controls high blood pressure but does not cure it. Continue to take indapamide even if you feel well. Do not stop taking indapamide without talking to your doctor.Indapamide also is used to treat swelling and fluid retention caused by various medical conditions other than heart disease. Talk to your doctor about the possible risks of using this medicine for your condition. Buy NATRILIX SR Lozol and other Prescription Drugs 11 products online at Medstore. Buy Online at Medstore - Click Here!
About NATRILIX SR Lozol: Product Type: Prescription Drugs 11 NATRILIX SR ( Lozol Generic Indapamide ) NATRILIX SR (Lozol Generic Indapamide) Lozol Generic Indapamide 1.5mg SR Tabs Lozol Generic Indapamide NATRILIX SR
View more Prescription Drugs 11 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
